Search results for E2

WEEV Spike glycoprotein E2 ELISA Kit, ProteoGenix, KPTX451

Description of WEEV Spike glycoprotein E2 ELISA Kit The Structure of WEEV Spike Glycoprotein E2 WEEV (Western Equine Encephalitis Virus) is a mosquito-borne virus that belongs to the Togaviridae family. It is primarily found in North and South America and is known to cause severe neurological diseases in humans and horses. The virus is composed of a single-stranded RNA genome surrounded by a lipid envelope. The envelope is made up of two glycoproteins, E1 and E2, which are responsible for viral entry and attachment to host cells. The E2 glycoprotein is the primary target for the development of vaccines and therapeutic agents against WEEV. It is a type I transmembrane protein that spans the viral envelope and is exposed on the surface of the virus. The E2 glycoprotein is composed of three distinct domains: the N-terminal domain, the central domain, and the C-terminal domain. The N-terminal domain is responsible for the attachment of the virus to host cells, while the central domain is involved in viral fusion and entry. The C-terminal domain is responsible for the assembly of the virus particles. The Activity of WEEV Spike Glycoprotein E2 The E2 glycoprotein plays a crucial role in the life cycle of WEEV. It is responsible for viral attachment, fusion, and entry into host cells. The N-terminal domain of the E2 glycoprotein binds to specific receptors on the surface of host cells, initiating the process of viral entry. The central domain then undergoes conformational changes, allowing the virus to fuse with the host cell membrane and release its genetic material into the cell. The C-terminal domain is involved in the assembly of the virus particles, which are then released from the host cell to infect other cells. The E2 glycoprotein is also a major target for the host immune response. Antibodies produced against this glycoprotein can neutralize the virus and prevent its entry into host cells. This makes the E2 glycoprotein an ideal target for the development of vaccines and therapeutics against WEEV. The Application of WEEV Spike Glycoprotein E2 ELISA Kit The WEEV Spike glycoprotein E2 ELISA Kit is a research tool used for the detection and quantification of the E2 glycoprotein in biological samples. This kit utilizes the enzyme-linked immunosorbent assay (ELISA) technique, which is based on the specific binding of antibodies to their target antigens. The WEEV Spike glycoprotein E2 ELISA Kit is primarily used for research purposes to study the structure and function of the E2 glycoprotein. It can also be used to measure the levels of E2 glycoprotein in biological samples, such as serum or tissue lysates, to monitor viral infection or the effectiveness of vaccines and therapeutics. Furthermore, the WEEV Spike glycoprotein E2 ELISA Kit can also be used as a diagnostic tool for the detection of WEEV infection in patients. The presence of high levels of E2 glycoprotein in serum samples can indicate an active infection, while a decrease in E2 glycoprotein levels can indicate a successful immune response to the virus. Conclusion In summary, the WEEV Spike glycoprotein E2 ELISA Kit is a valuable research tool for studying the structure, function, and activity of the E2 glycoprotein in WEEV. It has various applications in both research and diagnostics, making it a crucial tool for understanding and combating this mosquito-borne virus. With further advancements in technology, the WEEV Spike glycoprotein E2 ELISA Kit may also hold potential as a therapeutic target for the development of antiviral drugs against WEEV.

SUMO-1, Human, mAb 1B12-E2, Hycult Biotech, HM2327

Post-translational modification regulated by conjugation of a small ubiquitin-like modifier (SUMO) is involved in various cellular processes such as transcriptional regulation, apoptosis and nuclear transport. Recent proteomic analyses in mammalian cells revealed that a number of SUMO substrates and specific modifications by SUMO-1 are involved in essential processes, including chromatin organization, transcription, RNA metabolism, immunomodulation and development of the innate immune system.

Transcription Factor E2-Alpha (TCF3) Antibody, Abbexa, abx301780

TCF3 Antibody is a Rabbit Polyclonal against TCF3.

Anti-HPV16 E2 antibody [TVG 261], Abcam, AB17185

The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. E1 and E2 are proteins involved in the regulation of viral DNA replication. TVG 261 is useful for detection of protein in cervical lesions.

Anti-HPV16 E2 antibody [TVG 271], Abcam, AB17190

The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. E1 and E2 are proteins involved in the regulation of viral DNA replication. TVG 271 is useful for detection of protein in cervical lesions.

HRP Anti-Cyclin E2 antibody [EP454Y], Abcam, AB200425

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

PE Anti-Cyclin E2 antibody [E142], Abcam, AB211687

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Cyclin E2 antibody [EP454Y], Abcam, AB319438

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Hepatitis C virus E2 protein antibody, Genetex, GTX30878

Anti-PGE2/Prostaglandin E2 Antibody (2B5), AntibodySystem, RGN55301